Eastern European OTC market expansion will be "key driver" of future European growth.
This article was originally published in The Tan Sheet
Executive Summary
EASTERN EUROPEAN OTC MARKET EXPANSION A "KEY DRIVER" OF FUTURE GROWTH IN EUROPE, SmithKline Beecham Consumer Healthcare, Europe, Chairman Peter Jensen told the annual meeting of the European Proprietary Medicines Manufactures' Association (AESGP) in Lisbon, Portugal on June 8. With the inclusion of the Eastern European market, Jensen projected that overall European OTC sales could experience a "real growth" of 56%, totaling roughly $20.5 bil. by the year 2005.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning